Literature DB >> 51308

Letter: C1-esterase inactivators and C4 in malignant diseases.

N Bach-Martensen, K Osther, I Stroyer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 51308     DOI: 10.1016/s0140-6736(75)90571-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Characterization of C1 inhibitor binding to neutrophils.

Authors:  N S Chang; R J Boackle; R W Leu
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

2.  Complement Synthesis Influencing Factors Produced by Acute Myeloid Leukemia Blast Cells.

Authors:  Béla Schmidt; Márta Válay; Sarolta Nahajevszky; Ervin Pitlik; György Füst
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

3.  Depressed classical complement pathway activities in chronic lymphocytic leukaemia.

Authors:  G Füst; E Czink; D Minh; Z Miszlay; L Varga; S R Hollán
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

4.  Plasma levels of secretory IgA in patients with gastric cancer.

Authors:  G Ohshio; H Kudo; H Yoshioka; A Nonaka; T Manabe; T Tobe; Y Hamashima
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy.

Authors:  G Hauptmann; F Petitjean; J M Lang; F Oberling
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

6.  Serum C1-esterase inhibitor, an essential and independent prognosticator of gastric carcinoma.

Authors:  C W Janssen; R T Lie; H Maartmann-Moe; R Matre
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.